Mirae Asset Global Investments’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $97.4K | Buy |
1,914
+248
| +15% | +$12.6K | ﹤0.01% | 1141 |
|
2025
Q1 | $76.6K | Buy |
1,666
+66
| +4% | +$3.04K | ﹤0.01% | 1160 |
|
2024
Q4 | $66.5K | Sell |
1,600
-125
| -7% | -$5.2K | ﹤0.01% | 1220 |
|
2024
Q3 | $67K | Buy |
1,725
+318
| +23% | +$12.4K | ﹤0.01% | 1247 |
|
2024
Q2 | $46.6K | Sell |
1,407
-17,234
| -92% | -$571K | ﹤0.01% | 1263 |
|
2024
Q1 | $448K | Buy |
18,641
+1,246
| +7% | +$29.9K | ﹤0.01% | 1949 |
|
2023
Q4 | $514K | Buy |
17,395
+289
| +2% | +$8.53K | ﹤0.01% | 1955 |
|
2023
Q3 | $541K | Buy |
17,106
+3,069
| +22% | +$97K | ﹤0.01% | 1845 |
|
2023
Q2 | $358K | Buy |
14,037
+654
| +5% | +$16.7K | ﹤0.01% | 2102 |
|
2023
Q1 | $321K | Buy |
13,383
+3,238
| +32% | +$77.8K | ﹤0.01% | 2138 |
|
2022
Q4 | $198K | Buy |
+10,145
| New | +$198K | ﹤0.01% | 2305 |
|